Inner Mongolia Government Accepts Applications For SHI-Inclusion Of Compound Drugs
This article was originally published in PharmAsia News
The Department of Human Resources and Social Security of Inner Mongolia has started accepting applications from drug companies for their compound drugs, including infusions, to be covered by the region's Social Health Insurance
You may also be interested in...
The Phase III clinical trial showed a noticeable placebo effect compared with OV101.
The company will invest $1.2bn over the next four years to expand and upgrade its manufacturing capacity for pre-fillable syringes and advanced drug delivery systems across seven manufacturing facilities.
Beneficiaries in nursing homes and in rural areas will benefit from a telehealth expansion in the final CMS physician fee schedule rule.